VIRX

Viracta Therapeutics, Inc. Common Stock

Delisted

VIRX was delisted on the 3rd of February, 2025.

95 hedge funds and large institutions have $317M invested in Viracta Therapeutics, Inc. Common Stock in 2014 Q1 according to their latest regulatory filings, with 31 funds opening new positions, 32 increasing their positions, 22 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
95
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$9.11M
Puts
$3.94M
Net Calls
Net Calls Change

Top Buyers

1 +$22.1M
2 +$12.3M
3 +$9.12M
4
O
OrbiMed
New York
+$7.93M
5
HM
HealthCor Management
New York
+$4.56M

Top Sellers

1 -$6.79M
2 -$4.09M
3 -$2.45M
4
DCM
Decade Capital Management
New York
-$2.17M
5
D.E. Shaw & Co
D.E. Shaw & Co
New York
-$1.86M
Name Holding Trade Value Shares
Change
Change in
Stake
1
$56.3M
2
$37.3M
3
$32.2M
4
$29.9M
5
$23.1M
6
$12.3M
7
$10.6M
8
$9.12M
9
$8.32M
10
$7.93M
11
$6.84M
12
$5.26M
13
$4.56M
14
$4.07M
15
$3.64M
16
$3.32M
17
$3.14M
18
$3.01M
19
$2.83M
20
$2.83M
21
$2.79M
22
$2.78M
23
$2.38M
24
$2.31M
25
$2.26M